Back to Search
Start Over
Radiation Therapy Skin Marking with Lancets Versus Electric Marking Pen (COMFORTATTOO)—6 Months Results on Cosmesis, Fading, and Patients’ Satisfaction From a Randomized, Double-Blind Trial
- Source :
- Advances in Radiation Oncology, Vol 9, Iss 3, Pp 101404- (2024)
- Publication Year :
- 2024
- Publisher :
- Elsevier, 2024.
-
Abstract
- Purpose: Most of radiation oncology centers rely on set-up skin markings for patient setup during treatment delivery. Permanent dark-ink tattooing is the most popular marking method. COMFORTATTOO is a unicentric, randomized trial testing 2 permanent methods: lancets against an electric marking pen (Comfort Marker 2.0, CM). One substudy was undertaken to test if using the CM translates into a cosmesis, fading, or satisfaction benefit compared with the lancets. Methods and Materials: Patients aged 18 years or older referred to our department to receive RT were recruited. They were randomly assigned, in a 1:1 ratio, to receive set-up markings using lancets or CM. This substudy aimed to recruit all the living participants included in the main study. The primary endpoints were tattoos cosmesis, tattoos fading, and patients’ satisfaction 6 months after finishing the RT. Cosmetic and fading assessments were scored on a 5-point ascending scale and patients’ satisfaction on a 10-point ascending scale. The trial is registered at ClinicalTrials.gov (number NCT05371795). Results: Between April and September 2022, 92 patients were enrolled (45 assigned to lancets and 47 to CM) and assessed for the outcomes. Patients receiving CM had significantly better cosmetic markings, with a median score of 4.4 (vs 3.7 for lancets, P
Details
- Language :
- English
- ISSN :
- 24521094
- Volume :
- 9
- Issue :
- 3
- Database :
- Directory of Open Access Journals
- Journal :
- Advances in Radiation Oncology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.3b47186c74424426926d613462b6323c
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.adro.2023.101404